Is monthly administration of rituximab useful in ocular adnexal mucosa-associated lymphoid tissue lymphoma?

Not Applicable

• Conditions: Ocular adnexal mucosa-associated lymphoid tissue-type lymphoma (OAL)

• Registration Number: JPRN-UMIN000013117
• Lead Sponsor: Hiroshima University hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-02-10
• Study Completion: 2020-03-19
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

Not provided

Exclusion Criteria

1) The patient who has clear infection (virus infection is included) 2) The patient who has critical complications (hepatic insufficiency or renal insufficiency) 3) The patient who has a merger or anamnesis of critical cardiac disease (example: myocardial infarction, ischemic heart disease) 4) The patient who has critical digestive symptoms (advanced or serious nausea and vomiting, or diarrhea etc.) 5) The patient who shows a hepatitis B surface antigen, a HCV antibody, or HIV antibody-positive 6) The patient who has critical bleeding tendencies (diffuse-intravascular-coagulation syndrome etc.) 7) The patient who has clinical symptoms which make permeation in a central nervous system, or it suspect 8) The patient who has generation of heat of 38 or more degree C(however, in the case of tumor fever, it removes) 9) The patient who has interstitial pneumonia, pulmonary fibrosis, and pulmonary emphysema, or the patient accepted in the past 10) The patient who has active double cancer 11) The patient who has autoimmune hemolytic anemia, or the patient accepted in the past 12) A patient with the past of the critical hypersensitivity to mouse protein origin products, or an anaphylactic reaction 13) A pregnant woman or the patient that may have become pregnant, the patient under breast-feeding 14) The patient who cannot consent to contraception regardless of man and woman 15) In addition, the patient who judged that a doctor was unsuitable

Study & Design

• Study Type: Interventional
• Study Design: Not specified